Pyxis Oncology
Nicole Meiser possesses extensive experience in the biotechnology and pharmaceutical industries, currently serving in a CMC & External Manufacturing role at Pyxis Oncology since April 2021. Prior experience includes Associate Director of External Manufacturing at Editas Medicine and roles in process development and manufacturing at Leap Therapeutics, as well as senior management in biologics outsourcing at AVEO Oncology. Earlier in the career, Nicole held various positions at Stryker Biotech, culminating in a senior associate/manager role in purification process development. Responsibilities have consistently focused on ensuring quality and regulatory compliance, managing drug substance and product development, and leading cross-functional teams to achieve project goals. Nicole holds a Bachelor of Science degree in Biotechnology from the Rochester Institute of Technology, earned between 2000 and 2004.
Pyxis Oncology
2 followers
Pyxis Oncology is advancing a differentiated portfolio of potent biologics, including antibody-drug conjugates (ADCs) and monoclonal antibody (mAb) immunotherapies with the potential to help patients suffering from difficult-to-treat cancers.